ALNYLAM PHARMACEUTICALS, INC. (ALNY) › Shares OutstandingALNYLAM PHARMACEUTICALS, INC. (ALNY) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2009: 41.84M2010: 42.34M2011: 42.72M2012: 52.49M2013: 63.74M2014: 77.20M2015: 85.09M2016: 85.94M2017: 99.67M2018: 101.18M2019: 112.19M2020: 116.43M2021: 120.18M2022: 123.92M2023: 125.79M2024: 129.29M2025: 132.38M132.38M2009Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025132.38M+2.4%2024129.29M+2.8%2023125.79M+1.5%2022123.92M+3.1%2021120.18M+3.2%2020116.43M+3.8%2019112.19M+10.9%2018101.18M+1.5%201799.67M+16.0%201685.94M+1.0%201585.09M+10.2%201477.20M+21.1%201363.74M+21.4%201252.49M+22.9%201142.72M+0.9%201042.34M+1.2%200941.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share